ZESTAGEN S A has a total of 11 patent applications. Its first patent ever was published in 2011. It filed its patents most often in United States, Australia and Brazil. Its main competitors in its focus markets pharmaceuticals and biotechnology are DEBIOVISION INC, EPIMAB BIOTHERAPEUTICS INC and ALIOPHTHA AG.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 2 | |
#2 | Australia | 1 | |
#3 | Brazil | 1 | |
#4 | Canada | 1 | |
#5 | China | 1 | |
#6 | EPO (European Patent Office) | 1 | |
#7 | Israel | 1 | |
#8 | Republic of Korea | 1 | |
#9 | Mexico | 1 | |
#10 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Mamalaki Avgi | 9 |
#2 | Patsavoudi Evangelia | 9 |
#3 | Sidera Katerina | 9 |
#4 | Katerina Sidera | 1 |
#5 | Avgi Mamalaki | 1 |
#6 | Evangelia Patsavoudi | 1 |
Publication | Filing date | Title |
---|---|---|
KR20140016240A | Compositions and methods for treating neoplasia |